Travere Therapeutics, Inc. Common Stock
TVTX •
Buy Open
Signal type
Buy
Status
Open
Open Price
$29.73
Stop Loss
$27.78
Performance
41.71%
Days Open
15
Signal Setup
Signal Type Buy
Status Open
Open Date Mar 31, 2026
Open Price $29.73
Stop Loss $27.78
Timespan Day
Company Profile
Name Travere Therapeutics, Inc. Common Stock
Ticker TVTX
Market Cap $1.32B
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $42.13
List Date Jul 23, 2003
Description
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
Website Open Company Website